Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.

<h4>Background and aims</h4>Despite the high prevalence of chronic hepatitis B (CHB) in Africa, few studies have been performed among African patients. We sought to evaluate liver stiffness measurement by FibroScan® (LSM) and two biochemical scores (FibroTest®, Fibrometer®) to diagnose l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Papa Saliou Mbaye, Anna Sarr, Jean-Marie Sire, Marie-Louise Evra, Adama Ba, Jean Daveiga, Aboubakry Diallo, Fatou Fall, Loic Chartier, François Simon, Muriel Vray
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/810c4f67a0fa439ca27921dbd5f90ea6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:810c4f67a0fa439ca27921dbd5f90ea6
record_format dspace
spelling oai:doaj.org-article:810c4f67a0fa439ca27921dbd5f90ea62021-11-18T06:49:31ZLiver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.1932-620310.1371/journal.pone.0022291https://doaj.org/article/810c4f67a0fa439ca27921dbd5f90ea62011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21799814/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and aims</h4>Despite the high prevalence of chronic hepatitis B (CHB) in Africa, few studies have been performed among African patients. We sought to evaluate liver stiffness measurement by FibroScan® (LSM) and two biochemical scores (FibroTest®, Fibrometer®) to diagnose liver fibrosis in Senegalese CHB patients with HBV plasma DNA load ≥3.2 log(10) IU/mL and normal alanine aminotransferase (ALT) values.<h4>Methods</h4>LSM and liver fibrosis biochemical markers were performed on 225 consecutive HBV infected Senegalese patients with high viral load. Patients with an LSM range between 7 and 13 kPa underwent liver biopsy (LB). Two experienced liver pathologists performed histological grading using Metavir and Ishak scoring.<h4>Results</h4>225 patients were evaluated (84% male) and LB was performed in 69 patients, showing F2 and F3 fibrosis in 17% and 10% respectively. In these patients with a 7-13 kPa range of LSM, accuracy for diagnosis of significant fibrosis according to LB was unsatisfactory for all non-invasive markers with AUROCs below 0.70. For patients with LSM values below 7 kPa, FibroTest® (FT), and Fibrometer® (FM) using the cut-offs recommended by the test promoters suggested a fibrosis in 18% of cases for FT (8% severe fibrosis) and 8% for FM. For patients with LSM values greater than 13 kPa, FT, FM suggested a possible fibrosis in 73% and 70%, respectively.<h4>Conclusion</h4>In highly replicative HBV-infected African patients with normal ALT and LSM value below 13 kPa, FibroScan®, FibroTest® or Fibrometer® were unsuitable to predict the histological liver status of fibrosis.Papa Saliou MbayeAnna SarrJean-Marie SireMarie-Louise EvraAdama BaJean DaveigaAboubakry DialloFatou FallLoic ChartierFrançois SimonMuriel VrayPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 7, p e22291 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Papa Saliou Mbaye
Anna Sarr
Jean-Marie Sire
Marie-Louise Evra
Adama Ba
Jean Daveiga
Aboubakry Diallo
Fatou Fall
Loic Chartier
François Simon
Muriel Vray
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
description <h4>Background and aims</h4>Despite the high prevalence of chronic hepatitis B (CHB) in Africa, few studies have been performed among African patients. We sought to evaluate liver stiffness measurement by FibroScan® (LSM) and two biochemical scores (FibroTest®, Fibrometer®) to diagnose liver fibrosis in Senegalese CHB patients with HBV plasma DNA load ≥3.2 log(10) IU/mL and normal alanine aminotransferase (ALT) values.<h4>Methods</h4>LSM and liver fibrosis biochemical markers were performed on 225 consecutive HBV infected Senegalese patients with high viral load. Patients with an LSM range between 7 and 13 kPa underwent liver biopsy (LB). Two experienced liver pathologists performed histological grading using Metavir and Ishak scoring.<h4>Results</h4>225 patients were evaluated (84% male) and LB was performed in 69 patients, showing F2 and F3 fibrosis in 17% and 10% respectively. In these patients with a 7-13 kPa range of LSM, accuracy for diagnosis of significant fibrosis according to LB was unsatisfactory for all non-invasive markers with AUROCs below 0.70. For patients with LSM values below 7 kPa, FibroTest® (FT), and Fibrometer® (FM) using the cut-offs recommended by the test promoters suggested a fibrosis in 18% of cases for FT (8% severe fibrosis) and 8% for FM. For patients with LSM values greater than 13 kPa, FT, FM suggested a possible fibrosis in 73% and 70%, respectively.<h4>Conclusion</h4>In highly replicative HBV-infected African patients with normal ALT and LSM value below 13 kPa, FibroScan®, FibroTest® or Fibrometer® were unsuitable to predict the histological liver status of fibrosis.
format article
author Papa Saliou Mbaye
Anna Sarr
Jean-Marie Sire
Marie-Louise Evra
Adama Ba
Jean Daveiga
Aboubakry Diallo
Fatou Fall
Loic Chartier
François Simon
Muriel Vray
author_facet Papa Saliou Mbaye
Anna Sarr
Jean-Marie Sire
Marie-Louise Evra
Adama Ba
Jean Daveiga
Aboubakry Diallo
Fatou Fall
Loic Chartier
François Simon
Muriel Vray
author_sort Papa Saliou Mbaye
title Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
title_short Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
title_full Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
title_fullStr Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
title_full_unstemmed Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
title_sort liver stiffness measurement and biochemical markers in senegalese chronic hepatitis b patients with normal alt and high viral load.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/810c4f67a0fa439ca27921dbd5f90ea6
work_keys_str_mv AT papasalioumbaye liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT annasarr liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT jeanmariesire liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT marielouiseevra liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT adamaba liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT jeandaveiga liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT aboubakrydiallo liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT fatoufall liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT loicchartier liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT francoissimon liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
AT murielvray liverstiffnessmeasurementandbiochemicalmarkersinsenegalesechronichepatitisbpatientswithnormalaltandhighviralload
_version_ 1718424360772960256